CRISPR Therapeutics ($CRSP)

Description

CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease, including CASGEVY for eligible severe sickle cell disease and transfusion-dependent beta thalassemia patients.

CRISPR Therapeutics ($CRSP) is located in the Boston ecosystem.

Related

• Verve TherapeuticsSingle-course gene-editing therapies for cardiovascular disease. Cambridge MA; CRISPR-based PCSK9 + ANGPTL3 programs.
• Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• Sangamo Therapeutics ($SGMO)Develops genomic medicines using zinc finger technology for patients with severe diseases where current treatments may offer mainly symptom…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
• Esperion Therapeutics ($ESPR)Develops and commercializes medicines for cardiovascular disease, including cholesterol management, cardiovascular risk reduction, and…
• Intellia Therapeutics ($NTLA)Develops gene-editing medicines for serious diseases. Its clinical programmes use CRISPR delivered inside the body to treat inherited…
• Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…
• Prime Medicine ($PRME)Develops one-time genetic therapies using prime editing to locate genome targets and replace faulty DNA segments for patients with diseases…
• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
• Neumora TherapeuticsDevelops treatments for brain diseases, advancing CNS-targeted medicines and precision approaches to understand disease biology and…